[HTML][HTML] Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD
M Molimard, J Bourcereau, V Le Gros, I Bourdeix - Respiratory medicine, 2005 - Elsevier
Rationale: The Global Initiative for Chronic Obstructive Lung Disease guidelines
recommend bronchodilator reversibility testing to guide treatment decisions. This study …
recommend bronchodilator reversibility testing to guide treatment decisions. This study …
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD
M Molimard, J Bourcereau, V Le Gros… - Respiratory …, 2005 - pubmed.ncbi.nlm.nih.gov
Rationale The Global Initiative for Chronic Obstructive Lung Disease guidelines recommend
bronchodilator reversibility testing to guide treatment decisions. This study evaluated the …
bronchodilator reversibility testing to guide treatment decisions. This study evaluated the …
[PDF][PDF] Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD$
M Molimard, J Bourcereau, V Le Gros, I Bourdeix - Respiratory Medicine, 2005 - core.ac.uk
Summary Rationale: The Global Initiative for Chronic Obstructive Lung Disease guidelines
recommend bronchodilator reversibility testing to guide treatment decisions. This study …
recommend bronchodilator reversibility testing to guide treatment decisions. This study …
[HTML][HTML] Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD
M Molimard, J Bourcereau, V Le Gros… - Respiratory …, 2005 - resmedjournal.com
Summary Rationale: The Global Initiative for Chronic Obstructive Lung Disease guidelines
recommend bronchodilator reversibility testing to guide treatment decisions. This study …
recommend bronchodilator reversibility testing to guide treatment decisions. This study …
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD.
M Molimard, J Bourcereau, V Le Gros… - Respiratory …, 2005 - europepmc.org
Methods At Visit 1, patients (n= 448) with stable chronic obstructive pulmonary disease took
an FEV1 reversibility test using 200 microg salbutamol via a metered dose inhaler. At Visit 2 …
an FEV1 reversibility test using 200 microg salbutamol via a metered dose inhaler. At Visit 2 …
[引用][C] Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD
M MOLIMARD, J BOURCEREAU… - Respiratory …, 2005 - pascal-francis.inist.fr
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD
M Molimard, J Bourcereau, V Le Gros, I Bourdeix - Respiratory Medicine, 2005 - infona.pl
Rationale: The Global Initiative for Chronic Obstructive Lung Disease guidelines
recommend bronchodilator reversibility testing to guide treatment decisions. This study …
recommend bronchodilator reversibility testing to guide treatment decisions. This study …